Research Antibodies Market: By Product (Primary, Secondary), By Type (Monoclonal Antibodies, Polyclonal Antibodies), By Technology (Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Technologies), By Source (Mouse, Rabbit, Goat Sources), By Application (Infectious Diseases,Immunology, Oncology, Stem Cells, Neurobiology and Other Applications), By End User (Academic & Research Institutes, Contract Research Organizations and Pharmaceutical & Biotechnology Companies) and By Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Research Antibodies Market size was valued at USD 1.25 billion in 2022 and is expected to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The global market provides a detailed overview of the research antibodies market and that can be segmented by product, type, technology, source, application and end user. By product, the research antibodies market has been segmented into primary and secondary. The primary segment is likely to be the largest and fastest-growing segment in terms of product. Based on type, the research antibodies market is segmented into monoclonal antibodies and polyclonal antibodies. Among these, the monoclonal antibodies segment is expected to have the fastest-growing market during the forecast period 2023-2029. On the basis of technology, the market is segregated into immunohistochemistry, immunofluorescence, western blotting, flow cytometry, immunoprecipitation, ELISA and other technologies. The immunohistochemistry segment held considerable market share during the forecast period. Based on source, the market is segregated into mouse, rabbit, goat and other sources. The mouse segment held considerable market share during the forecast period. By application, market is segmented into infectious diseases, immunology, oncology, stem cells, neurobiology and other applications. Infectious diseases segment held substantial market growth during estimated period. On the basis of End User, market is segregated into Academic & Research Institutes, Contract Research Organizations and Pharmaceutical & Biotechnology Companies

Research Antibodies Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.2%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Research Antibodies Market Dynamics

These strong R&D activities for the creation of new vaccination and treatment methods have significantly boosted the need for research antibodies. Additionally, numerous government and private organizations are working very hard to raise money for the creation of COVID-19 vaccines and treatments. The rise in demand for high-quality antibodies for reproducible research is one of the main factors driving the research antibodies market. The research antibodies market is expanding as a result of rising proteomics and genomics research fields and expanded life sciences research and development initiatives.

Key Features of the Reports

  • The research antibodies market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Research Antibodies Market Segmentation

By Product
  • Primary
  • Secondary
By Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
By Technology
  • Immunohistochemistry
  • Immunofluorescence
  • Western Blotting
  • Flow Cytometry
  • Immunoprecipitation
  • ELISA
  • Technologies
By Source
  • Mouse
  • Rabbit
  • Goat
  • Sources
By Application
  • Infectious Diseases
  • Immunology
  • Oncology
  • Stem Cells
  • Neurobiology
By End User
  • Academic and Research Institutes
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies

Frequently Asked Questions

The research antibodies market is projected to expand at a CAGR of 4.2% during the forecast period

The major players in the global research antibodies market are Abcam Plc, Bio-rad Laboratories, Becton Dickinson & Company, Merck Millipore, Lonza Group, Thermo Fisher Scientific, Inc., Cell Signalling Technology, Inc., F. Hoffmann La Roche Ltd., Agilent Technologies and Perkinelmer, Inc.

North America is the fastest-growing region for research antibodies market

1.Executive Summary
2.Global Research Antibodies Market Introduction 
2.1.Global Research Antibodies Market  - Taxonomy
2.2.Global Research Antibodies Market  - Definitions
2.2.1.Product
2.2.2.Type
2.2.3.Technology
2.2.4.Source
2.2.5.Region
3.Global Research Antibodies Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Research Antibodies Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Research Antibodies Market By Product, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Primary
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Secondary
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Research Antibodies Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Monoclonal Antibodies
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Polyclonal Antibodies
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Research Antibodies Market By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Immunohistochemistry
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Immunofluorescence
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Western Blotting
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Flow Cytometry
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Immunoprecipitation
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. ELISA
7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Technologies
7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8.Global Research Antibodies Market By Source, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Mouse
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Rabbit
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Goat
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Sources
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Research Antibodies Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Research Antibodies Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Primary
10.1.2.Secondary
10.2.  Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Monoclonal Antibodies
10.2.2.Polyclonal Antibodies
10.3.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Immunohistochemistry
10.3.2.Immunofluorescence
10.3.3.Western Blotting
10.3.4.Flow Cytometry
10.3.5.Immunoprecipitation
10.3.6.ELISA
10.3.7.Technologies
10.4.  Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Mouse
10.4.2.Rabbit
10.4.3.Goat
10.4.4.Sources
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Research Antibodies Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Primary
11.1.2.Secondary
11.2.  Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Monoclonal Antibodies
11.2.2.Polyclonal Antibodies
11.3.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Immunohistochemistry
11.3.2.Immunofluorescence
11.3.3.Western Blotting
11.3.4.Flow Cytometry
11.3.5.Immunoprecipitation
11.3.6.ELISA
11.3.7.Technologies
11.4.  Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Mouse
11.4.2.Rabbit
11.4.3.Goat
11.4.4.Sources
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Research Antibodies Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Primary
12.1.2.Secondary
12.2.  Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Monoclonal Antibodies
12.2.2.Polyclonal Antibodies
12.3.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Immunohistochemistry
12.3.2.Immunofluorescence
12.3.3.Western Blotting
12.3.4.Flow Cytometry
12.3.5.Immunoprecipitation
12.3.6.ELISA
12.3.7.Technologies
12.4.  Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Mouse
12.4.2.Rabbit
12.4.3.Goat
12.4.4.Sources
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Research Antibodies Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Primary
13.1.2.Secondary
13.2.  Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Monoclonal Antibodies
13.2.2.Polyclonal Antibodies
13.3.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Immunohistochemistry
13.3.2.Immunofluorescence
13.3.3.Western Blotting
13.3.4.Flow Cytometry
13.3.5.Immunoprecipitation
13.3.6.ELISA
13.3.7.Technologies
13.4.  Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Mouse
13.4.2.Rabbit
13.4.3.Goat
13.4.4.Sources
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Research Antibodies Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Primary
14.1.2.Secondary
14.2.  Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Monoclonal Antibodies
14.2.2.Polyclonal Antibodies
14.3.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Immunohistochemistry
14.3.2.Immunofluorescence
14.3.3.Western Blotting
14.3.4.Flow Cytometry
14.3.5.Immunoprecipitation
14.3.6.ELISA
14.3.7.Technologies
14.4.  Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Mouse
14.4.2.Rabbit
14.4.3.Goat
14.4.4.Sources
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abcam Plc
15.2.2.Bio-rad Laboratories
15.2.3.Becton Dickinson & Company
15.2.4.Merck Millipore
15.2.5.Lonza Group
15.2.6.Thermo Fisher Scientific
15.2.7.Cell Signalling Technology
15.2.8.Hoffmann La Roche
15.2.9.Agilent Technologies
15.2.10.Perkinelmer, Inc.
16. Research Methodology 
17. Appendix and Abbreviations 
  • Abcam Plc
  • Bio-rad Laboratories
  • Becton Dickinson & Company
  • Merck Millipore
  • Lonza Group
  • Thermo Fisher Scientific
  • Cell Signalling Technology
  • Hoffmann La Roche
  • Agilent Technologies
  • Perkinelmer, Inc.

Adjacent Markets